Hip bursitis vs. arthritis: How to tell the difference
Fitness for longevity: Which type matters most?
Ministrokes linked to elevated risk of dementia
Continuous glucose monitors benefit people who don't need insulin
CoQ10: Should you take this popular supplement if you're on a statin?
Microplastics: A hidden health threat?
Oat vs. dairy milk: Nutrition, benefits, and downsides
What is tempeh? Benefits, nutrition, and how to use it
Healing after food poisoning
Whole grains may improve several heart risk factors at once
Guru P. Sonpavde, MD
Contributor
Guru P. Sonpavde, MD is the director of the bladder cancer program at Dana-Farber Cancer Institute and is on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus is on clinical trials to develop new drugs and combinations to treat urologic cancers, particularly bladder cancer. He also has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. He is a member of the Genitourinary Committee of Southwest Oncology Group and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee.
Posts by Guru P. Sonpavde, MD
Guru P. Sonpavde, MD
Cancer treatment: Is a clinical trial right for you?
Healthy aging and longevity
Immunotherapy: What you need to know
Hip bursitis vs. arthritis: How to tell the difference
Fitness for longevity: Which type matters most?
Ministrokes linked to elevated risk of dementia
Continuous glucose monitors benefit people who don't need insulin
CoQ10: Should you take this popular supplement if you're on a statin?
Microplastics: A hidden health threat?
Oat vs. dairy milk: Nutrition, benefits, and downsides
What is tempeh? Benefits, nutrition, and how to use it
Healing after food poisoning
Whole grains may improve several heart risk factors at once
